Vein360

What Vein360 does

Vein360 is a US-based, FDA-regulated medical device reprocessing company founded in 2015 and headquartered in Blue Ash, Ohio. The company acquires once-used complex vascular catheters—specifically Philips IVUS (Intravascular Ultrasound) catheters and Medtronic ClosureFast radiofrequency ablation (RFA) catheters—through a buyback program from healthcare practices, then reprocesses and resells them at a discount relative to new OEM devices. Its core technology combines automated cleaning using advanced chemistry and mechanical energy with rigorous in-line testing on flexible circuits and 64-element transducer arrays, multi-point visual inspections, and electro-mechanical performance tests designed to validate that each reprocessed device is substantially equivalent to a new, unused unit. The company holds multiple FDA 510(k) clearances (K191073, K230584, K230928, K232584) covering its reprocessed catheter portfolio, and it sells a Basic Procedure Pack as an accessory.

Vein360 serves US vein centers, vascular surgery practices, and general healthcare clinics that perform IVUS imaging, peripheral and venous interventions, and endovenous RFA procedures. It generates revenue through direct enterprise sales of reprocessed catheters under a quote-based B2B model, complemented by a buyback stream that recovers used devices from clinic partners. The go-to-market is exclusively direct field/enterprise sales with phone and web-based quote requests, supported by educational content, an FDA clearance transparency page, and a value proposition centered on cost reduction, quality parity to new devices, and reduction of medical-device landfill waste.

The leadership team is led by founder and CEO Suzanne Meyer (a biomedical engineer and recognized Top 25 Women in Medical Devices honoree), founder and CMO Dr. Christopher Meyer (a practicing vascular surgeon who runs Florida Vein Care Specialists), and VP Operations Seth Masek (a 25-year veteran and founding member of the first medical device reprocessing company). Vein360 also positions itself as a procurement advisor to practices seeking to navigate or exit anti-competitive OEM capital-equipment 'tower agreements.' The company is a privately held LLC, has 11-50 employees, has no disclosed outside funding, and operates exclusively within the United States.

Name

Vein360

Legal name

Vein360 LLC

Website

https://vein360.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Vein360 is a US-based, FDA-cleared medical device reprocessor that buys once-used Philips IVUS and Medtronic ClosureFast RFA catheters from vein centers, reprocesses them to OEM-equivalent quality, and resells them at a discount to healthcare practices across the United States.

Ownership category

akta.pro rank

Product category

Medical Device Reprocessing

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Sterilization Services & Contract Reprocessing (ETO/Gamma/E-beam providers) (HLAHANAB)

akta.pro secondary industry

Vascular Access Devices (AV Grafts, Catheters, Fistula Accessories) (HLAHAKAE)

Keywords

• Medical device reprocessing
• IVUS catheters
• RFA catheters
• Vein care supplies
• Healthcare supply chain

Headquarters

HQ city

Ohio

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Reprocessed Medical Device Sales: Vein360 generates revenue by selling FDA-cleared reprocessed IVUS and RFA catheters to vein centers and medical practices. The company acquires used single-use catheters through its buyback program, reprocesses them to original equipment standards, and resells them at significantly reduced prices compared to new OEM devices.
2. Device Buyback Program: Vein360 purchases used IVUS and RF catheters from medical practices, which serves as the supply source for their reprocessing operations while providing cost recovery for clinic partners.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Vein360 reprocesses FDA-cleared Philips IVUS (Intravascular Ultrasound) catheters and Medtronic ClosureFast RFA (Radiofrequency Ablation) catheters used in vein treatment procedures. The company acquires once-used single-use catheters from medical practices through a buyback program, validates and reprocesses them to original equipment manufacturer quality standards, and resells them to vein centers and medical practices at significantly reduced prices compared to new OEM devices.

Product overview

Vein360 is a medical device reprocessing company specializing in complex vascular catheters. Their product portfolio consists of two main categories: Reprocessed Philips IVUS (Intravascular Ultrasound) Catheters (Eagle Eye Platinum, Eagle Eye Platinum ST, Visions PV .014P RX, Visions PV .018, and Visions PV .035) for vascular imaging and morphology assessment; and Reprocessed Medtronic ClosureFast RFA (Radiofrequency Ablation) Catheters (VEN-7-60B, VEN-3-60B, and VEN-7-100B) for vein closure procedures. All products undergo rigorous multi-point visual inspections and electro-mechanical testing to ensure quality equivalent to new devices. The company also offers Basic Procedure Packs as accessories. All products are FDA 510(k) cleared and are designed for compatibility with OEM capital equipment (Philips IVUS towers and Medtronic RF generators). Vein360 operates a buyback program for once-used catheters and assists practices in navigating capital equipment/tower agreements.

Differentiator

Problem solved

Functional benefit

Products and services

• Vein360 Reprocessed Eagle Eye Platinum Catheter Digital IVUS catheter with plug-and-play simplicity, gently tapered tip, enhanced hydrophilic coating, rapid exchange lumen, three radiopaque markers, and seamless compatibility with all Philips IVUS towers. Designed for vascular morphology assessment and intravascular ultrasound imaging.
• Vein360 Reprocessed Eagle Eye Platinum ST Catheter Digital IVUS catheter with a 2.5mm tip-to-imaging distance for assessing severely stenotic lesions and distal anatomy. Compatible with all 5F guide catheters and Philips IVUS towers.
• Vein360 Reprocessed Visions PV .014P RX Catheter Digital IVUS catheter with a 55% firmer shaft compared to the Eagle Eye Platinum, promoting increased pushability without compromising trackability. Used for peripheral lesion diagnosis.
• Vein360 Reprocessed Visions PV .018 Catheter Digital IVUS catheter with a 135cm working length, 24mm maximum imaging diameter, and compatibility with a 0.018-inch guide wire. Used for diagnosing peripheral lesions.
• Vein360 Reprocessed Visions PV .035 Catheter Digital IVUS catheter with a 90cm working length, 60mm maximum imaging diameter, and 10MHz frequency. Used for assessing vascular morphology and diagnosing peripheral artery and venous disease.
• Vein360 Reprocessed ClosureFast Catheter (VEN-7-60B) RFA catheter applying 20 seconds of precise 120°C heat to 7cm vein segments for reliable vein closure. 60cm insertable length, compatible with RFG2 (4.0.0+) and RFG3 (1.11.0+) generators.
• Vein360 Reprocessed ClosureFast Catheter (VEN-3-60B) RFA catheter applying 20 seconds of precise 120°C heat to 3cm vein segments for reliable vein closure. 60cm insertable length, 18W max power setting.
• Vein360 Reprocessed ClosureFast Catheter (VEN-7-100B) RFA catheter applying 20 seconds of precise 120°C heat to 7cm vein segments. 100cm insertable length, 40W max power setting, compatible with RFG2 (4.0.0+) and RFG3 (1.11.0+) generators.
• Vein360 Basic Procedure Pack Procedure pack containing drape, syringes, ultrasound gel, utility bowl, spinal needle, table cover, probe cover kit, and gauze sponges for vein procedures.
• Vein360 Catheter Buyback Program Program in which Vein360 purchases used IVUS and RFA catheters from medical practices. The buyback provides cost recovery to clinics while supplying Vein360 with once-used devices for reprocessing and resale.

Quantifiable outcome

• Delivered millions of dollars in healthcare supply chain savings to clinic partners
• +2 more outcomes

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• U.S. Food and Drug Administration (FDA)coreOthersVein360 operates under FDA oversight through 510(k) premarket clearance process. The company submitted comprehensive validation data to the FDA for each reprocessed device, which was rigorously scrutinized by independent scientific experts. FDA determined Vein360's reprocessed products are substantially equivalent to new, unused devices in terms of cleanliness, sterility, functionality, and biocompatibility.

Scale indicators3 records

Recent moves5 records

Expansion highlights3 records

Market position

Competitive moat4 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vein360